Case number 1:18-cv-00175
H. Lundbeck A/S et al v. Amneal Pharmaceuticals LLC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 30 | Motion for Miscellaneous Relief (4) |
| Jul 8, 2020 | 18 | Motion to Dismiss/Lack of Personal Jurisdiction (4) |
| Jul 8, 2020 | 1 | Complaint (26) |
| Jan 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 1/16/2019. Associated Cases: 1:18-cv-00088-LPS et al.(dlb) |
| Jan 10, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00088-LPS et al.(cak) |
| Dec 27, 2018 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 170 in lead case no. 18-88-LPS). (ntl) |
| Jul 9, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00088-LPS. (ntl) |
| Jul 3, 2018 | 43 | Main Document (22) Docket Text: PROPOSED ORDER -- Scheduling Order -- by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Blumenfeld, Jack) |
| Jul 3, 2018 | 43 | Letter to The Honorable Leonard P. Stark (1) |
| Jul 3, 2018 | 43 | Proposed Order (22) |
| Jun 19, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Case Management Conference held on 6/19/2018. (Court Reporter: Hawkins Reporting) Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 12, 2018 | 42 | Main Document (23) Docket Text: PROPOSED ORDER Scheduling Order by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Cover Letter)(Blumenfeld, Jack) |
| Jun 12, 2018 | 42 | Cover Letter (1) |
| Jun 12, 2018 | 42 | Proposed Order (23) |
| Jun 8, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 1:18-cv-00177-LPS, 21 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00114-LPS, 17 in 1:18-cv-00147-LPS, 41 in 1:18-cv-00175-LPS, 15 in 1:18-cv-00092-LPS, 12 in 1:18-cv-00672-LPS, 13 in 1:18-cv-00671-LPS, 28 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00113-LPS, 11 in 1:18-cv-00753-LPS, 9 in 1:18-cv-00777-LPS, 23 in 1:18-cv-00148-LPS, 20 in 1:18-cv-00150-LPS, 20 in 1:18-cv-00176-LPS, 19 in 1:18-cv-00091-LPS, 17 in 1:18-cv-00090-LPS, 16 in 1:18-cv-00149-LPS) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 6/7/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 6, 2018 | 41 | Stipulation to EXTEND Time (14) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack) |
| May 31, 2018 | N/A | SO ORDERED (0) |
| May 30, 2018 | 40 | Stipulation (6) Docket Text: STIPULATION and Order Dismissing Defendant Raks Pharma Private Limited Without Prejudice and Amending Caption to Reflect Same by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, Raks Pharma Private Limited. (Gaza, Anne) |
| May 24, 2018 | 39 | Disclosure Statement (4) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals Holding GmbH for Amneal Pharmaceuticals Company GmbH; Corporate Parent Amneal Pharmaceuticals LLC for Amneal Pharmaceuticals of New York, LLC; Corporate Parent Amneal Pharmaceuticals, Inc., Corporate Parent APHC Holdings, LLC for Amneal Pharmaceuticals LLC filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC. (Gaza, Anne) |
| May 23, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Court will hold a Case Management Conference in courtroom 6B on June 19, 2018 at 9:00 a.m. In preparation for the CMC, counsel shall meet and confer and address the items listed in the "Checklist," and submit a proposed scheduling order no later than June 6, 2018. ORDERED by Judge Leonard P. Stark on 5/23/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| May 23, 2018 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Court will hear argument on the motion to dismiss on June 19, 2018 beginning at 9:00 a.m. Each side will be allocated up to 45 minutes to present its argument. ORDERED by Judge Leonard P. Stark on 5/23/18. (ntl) |
| May 17, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Corrected exhibits added to D.I. [29] per request of counsel. (ntl) |
| May 16, 2018 | 36 | Redacted Document (29) Docket Text: REDACTED VERSION of [31] Reply Brief by Raks Pharma Private Limited. (Wilson, Samantha) |
| May 16, 2018 | 35 | Request for Oral Argument (4) Docket Text: REQUEST for Oral Argument by Raks Pharma Private Limited re [18] MOTION to Dismiss for Lack of Jurisdiction Over the Person . (Gaza, Anne) |
| May 16, 2018 | 34 | Order (1) Docket Text: ORDER re [30] MOTION for Leave to File Reply Brief Under Seal [Unopposed] filed by Raks Pharma Private Limited. Signed by Judge Leonard P. Stark on 5/16/18. (ntl) |
| May 14, 2018 | 33 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Singapore Pvt. Ltd. for Amneal Pharmaceuticals Pvt. Ltd., Raks Pharma Private Limited filed by Amneal Pharmaceuticals Pvt. Ltd., Raks Pharma Private Limited. (Gaza, Anne) |
| May 14, 2018 | 32 | Answer to Amended Complaint (22) Docket Text: ANSWER to Amended Complaint, re: [7] Amended Complaint, by Amneal Pharmaceuticals Pvt. Ltd..(Gaza, Anne) |
| May 11, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael R. Dzwonczyk for Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, and Raks Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| May 9, 2018 | 30 | D. Del. LR 7.1.1. Certification (1) |
| May 9, 2018 | 30 | Text of Proposed Order (1) |
| May 9, 2018 | 30 | Main Document (4) Docket Text: MOTION for Leave to File Reply Brief Under Seal [Unopposed] - filed by Raks Pharma Private Limited. (Attachments: # (1) Text of Proposed Order, # (2) D. Del. LR 7.1.1. Certification)(Gaza, Anne) |
| May 8, 2018 | N/A | SO ORDERED (0) |
| May 8, 2018 | N/A | SO ORDERED (0) |
| May 7, 2018 | 29 | Redacted Document (25) |
| May 7, 2018 | 29 | Exhibit 1 - 13 (45) |
| May 7, 2018 | 29 | Main Document (25) Docket Text: REDACTED VERSION of [25] Answering Brief in Opposition, by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Exhibit 1 - 13)(Noreika, Maryellen) (Attachment 1 replaced on 5/17/2018) (ntl). |
| May 4, 2018 | N/A | SO ORDERED (0) |
| May 4, 2018 | 27 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Partial Withdrawal of Motion to Dismiss and Answer Deadline as to Amneal Pharmaceuticals Pvt. Ltd. by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, Raks Pharma Private Limited. (Gaza, Anne) |
| May 4, 2018 | 28 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Raks Pharma Private Limited to file its reply in support of its motion to dismiss for lack of jurisdiction to May 9, 2018 - filed by Raks Pharma Private Limited. (Gaza, Anne) |
| May 3, 2018 | 26 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael R. Dzwonczyk and Attorney Mark Boland - filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, Raks Pharma Private Limited. (Wilson, Samantha) |
| Apr 27, 2018 | 24 | Answer to Counterclaim (13) Docket Text: ANSWER to [16] Answer to Amended Complaint,, Counterclaim, by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc..(Blumenfeld, Jack) |
| Apr 26, 2018 | N/A | SO ORDERED (0) |
| Apr 25, 2018 | 23 | Motion for Leave to Appear Pro Hac Vice (19) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda of Covington & Burling LLP - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Dellinger, Megan) |
| Apr 23, 2018 | N/A | SO ORDERED (0) |
| Apr 20, 2018 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for plaintiffs to respond to Amneal Pharmaceuticals Pvt. Ltd. and Raks Pharma Private Limited's motion to dismiss for lack of jurisdiction to April 30, 2018 - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack) |
| Apr 9, 2018 | N/A | CORRECTING ENTRY: (0) |
| Apr 6, 2018 | 21 | Opening Brief in Support (22) Docket Text: OPENING BRIEF in Support re [18] MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Amneal Pharmaceuticals Pvt. Ltd., Raks Pharma Private Limited.Answering Brief/Response due date per Local Rules is 4/20/2018. (Gaza, Anne) (Main Document 21 replaced on 4/9/2018) (ntl). |
| Apr 6, 2018 | 20 | Declaration (6) Docket Text: DECLARATION re [18] MOTION to Dismiss for Lack of Jurisdiction Over the Person of Kanwal Pandita, Ph.D. by Amneal Pharmaceuticals Pvt. Ltd., Raks Pharma Private Limited. (Gaza, Anne) |
| Apr 6, 2018 | 19 | Declaration (6) Docket Text: DECLARATION re [18] MOTION to Dismiss for Lack of Jurisdiction Over the Person of Jatin Gajjar by Amneal Pharmaceuticals Pvt. Ltd., Raks Pharma Private Limited. (Gaza, Anne) |
| Apr 6, 2018 | 18 | Text of Proposed Order (1) |
| Apr 6, 2018 | 17 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals Holdings, GmbH for Amneal Pharmaceuticals Company GmbH; Corporate Parent AmnealPharmaceuticals LLC for Amneal Pharmaceuticals of New York, LLC; Corporate Parent Amneal Pharmaceuticals Holding Company LLC, Corporate Parent Amneal Holdings, LLC for Amneal Pharmaceuticals LLC filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC. (Gaza, Anne) |
| Apr 6, 2018 | 16 | Answer to Amended Complaint (25) Docket Text: ANSWER to Amended Complaint, re: [7] Amended Complaint, , COUNTERCLAIM against H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals of New York, LLC.(Gaza, Anne) |
| Apr 6, 2018 | 18 | Main Document (4) Docket Text: MOTION to Dismiss for Lack of Jurisdiction Over the Person - filed by Amneal Pharmaceuticals Pvt. Ltd., Raks Pharma Private Limited. (Attachments: # (1) Text of Proposed Order)(Gaza, Anne) |
| Mar 27, 2018 | N/A | SO ORDERED (0) |
| Mar 22, 2018 | 13 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceuticals International AG, Takeda Pharmaceutical Company Ltd.: For Amneal Pharmaceuticals Pvt. Ltd. waiver sent on 3/19/2018, answer due 5/18/2018. (Noreika, Maryellen) |
| Mar 22, 2018 | 12 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Amneal Pharmaceuticals Pvt. Ltd. on 3/19/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 4/18/2018. (Noreika, Maryellen) |
| Mar 22, 2018 | 14 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Raks Pharma Private Limited on 3/19/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 4/18/2018. (Noreika, Maryellen) |
| Mar 22, 2018 | 15 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceuticals International AG, Takeda Pharmaceutical Company Ltd.: For Raks Pharma Private Limited waiver sent on 3/19/2018, answer due 5/18/2018. (Noreika, Maryellen) |
| Mar 16, 2018 | 11 | Stipulation (4) Docket Text: STIPULATION and [Proposed Order] Regarding Service and Extensions of Time for Defendants to Respond to the First Amended Complaint by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, Raks Pharma Private Limited. (Gaza, Anne) |
| Feb 26, 2018 | 10 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceuticals International AG, Takeda Pharmaceutical Company Ltd.. Amneal Pharmaceuticals of New York, LLC served on 2/23/2018, answer due 3/16/2018. (Noreika, Maryellen) |
| Feb 26, 2018 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceuticals International AG, Takeda Pharmaceutical Company Ltd.. Amneal Pharmaceuticals LLC served on 2/23/2018, answer due 3/16/2018. (Noreika, Maryellen) |
| Feb 23, 2018 | 7 | Amended Complaint (29) |
| Feb 23, 2018 | 8 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,861,630 B1; . (Blumenfeld, Jack) |
| Feb 23, 2018 | 7 | Exhibit A - F (219) |
| Feb 23, 2018 | 7 | Main Document (29) Docket Text: First AMENDED COMPLAINT against Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, Raks Pharma Private Limited- filed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceuticals International AG, Takeda Pharmaceutical Company Ltd.. (Attachments: # (1) Exhibit A - F)(Blumenfeld, Jack) |
| Feb 7, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-00175-UNA, 1:18-cv-00176-UNA, 1:18-cv-00177-UNA(nms) |
| Jan 31, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Amneal Pharmaceuticals Company GmbH on 1/31/2018; Amneal Pharmaceuticals LLC on 1/31/2018; Amneal Pharmaceuticals Pvt. Ltd. on 1/31/2018; Amneal Pharmaceuticals of New York, LLC on 1/31/2018; Raks Pharma Private Limited on 1/31/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Jan 30, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc.; Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc.; Corporate Parent Takeda Pharma A/S, Corporate Parent Takeda Europe Holdings B.V. for Takeda Pharmaceuticals International AG filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (nmg) |
| Jan 30, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (nmg) |
| Jan 30, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,144,884 B2; 8,476,279 B2; 8,722,684 B2; 8,969,355 B2; 9,227,946 B2. (nmg) |
| Jan 30, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/20/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/30/2021. (nmg) |
| Jan 30, 2018 | 1 | Main Document (26) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC, Raks Pharma Private Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2312155.) - filed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceuticals International AG, Takeda Pharmaceutical Company Ltd.. (Attachments: # (1) Exhibit A-E, # (2) Civil Cover Sheet)(nmg) |
| Jan 30, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jan 30, 2018 | 1 | Civil Cover Sheet (2) |
| Jan 30, 2018 | 1 | Exhibit A-E (172) |
| Jan 30, 2018 | 1 | Complaint* (1) |
